Posts by: Patricia Silva, PhD

Patricia Silva, PhD

Patrícia holds her PhD in Medical Microbiology and Infectious Diseases from the Leiden University Medical Center in Leiden, The Netherlands. She has studied Applied Biology at Universidade do Minho and was a postdoctoral research fellow at Instituto de Medicina Molecular in Lisbon, Portugal. Her work has been focused on molecular genetic traits of infectious agents such as viruses and parasites.

December 22, 2015February 9, 2016

Type 1 Diabetes Therapy Aiming to Improve on Insulin Heads into Clinical Trial

News

REMD Biotherapeutics, Inc., along with its Beijing-based subsidiary Cosci-REMD Biotherapeutics, recently announced that the U.S. Food and Drug Administration has approved the company’s clinical study to assess its drug candidate REMD-477 ... Read more

December 16, 2015December 16, 2015

Bariatric Surgery Reported as Effective Strategy to Induce Diabetes Remission

News

A new study published in the journal Diabetes Care revealed that bariatric surgery is more effective in inducing diabetes remission than medical control. The study is entitled “Determinants of Diabetes ... Read more

December 14, 2015

Diabetes Monitoring System Using a Phone App Approved by FDA

News

Philosys, a company developing medical, analytical and diagnostic instruments, recently announced that the U.S. Food and Drug Administration (FDA) has approved its Gmate SMART Blood Glucose Monitoring System and App for Android. ... Read more

December 4, 2015February 9, 2016

New Type 2 Diabetes Treatment Shows Encouraging Results in Early Phase 2 Trial

News

ProMetic Life Sciences Inc., a biopharmaceutical company focused on the development of small-molecule drugs and plasma-derived therapeutics, recently announced that it has ended the patient enrollment phase on its Phase ... Read more

December 3, 2015December 3, 2015

Poxel Presents New Data on Promising Anti-Diabetic Drugs

News

Poxel SA, a biopharmaceutical company dedicated to novel treatments for type 2 diabetes, recently announced positive clinical and preclinical data on the company’s lead products, Imeglimin and PXL770. The data were presented ... Read more

December 2, 2015December 2, 2015

Breastfeeding Found to Reduce Type 2 Diabetes Risk in Women with Gestational Diabetes

News, Type 2 Diabetes News

A new study recently published in the journal Annals of Internal Medicine revealed that women with a diagnosis of gestational diabetes can benefit from breastfeeding their infants. The study is ... Read more

November 30, 2015November 30, 2015

Genetic Test for Diabetes Developed by UK Scientists

News

A recent study, led by researchers at the University of Exeter, U.K., revealed a new diagnostic method for diabetes that may lead to more effective disease diagnosis and patient care. The ... Read more

November 20, 2015

Update on Severe Obesity-Linked Type 2 Diabetes Therapy from Zafgen

News

Zafgen, Inc., a biopharmaceutical company focused on therapies for obesity and complex metabolic disorders, recently announced a clinical update on its product candidate beloranib. Beloranib is a first-in-class, twice-weekly, subcutaneous ... Read more

November 19, 2015January 5, 2016

Engineered Micro Pancreas Raises Hope for Type 1 Diabetes Treatment

News

Betalin Therapeutics, an Israeli biotechnology company specializing in diabetes treatments, recently announced the development of a new technology called Engineered Micro Pancreas (EMP) that enables the secretion of significant levels of glucose-regulated insulin ... Read more

November 18, 2015

Canadian Diabetes Association Recommends Tax on Sugar-Sweetened Beverages to Prevent Type 2 Diabetes

News

The Canadian Diabetes Association (CDA) recently announced the recommendation of a tax on sugar-sweetened beverages (SSBs) in the context of the upcoming federal election. The association believes that this tax might ... Read more